Triple

T5873234
Position Surface form Disambiguated ID Type / Status
Subject HMA Multi-Annual Work Plan E130566 entity
Predicate isAlignedWith P2830 FINISHED
Object European Medicines Agency network strategy E3950 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: European Medicines Agency network strategy | Statement: [HMA Multi-Annual Work Plan, isAlignedWith, European Medicines Agency network strategy]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07 
Target entity: European Medicines Agency network strategy
Context triple: [HMA Multi-Annual Work Plan, isAlignedWith, European Medicines Agency network strategy]
  • A. European medicines regulatory authorities
    European medicines regulatory authorities are national and regional agencies in Europe responsible for evaluating, authorizing, and monitoring the safety, quality, and efficacy of medicinal products.
  • B. European Medicines Agency chosen
    The European Medicines Agency is the European Union’s regulatory authority responsible for the scientific evaluation, supervision, and safety monitoring of medicines for human and veterinary use.
  • C. European Union pharmaceutical legislation
    European Union pharmaceutical legislation is the body of EU laws and regulations that governs the authorization, supervision, safety, and quality of medicines for human and veterinary use across member states.
  • D. European Directorate for the Quality of Medicines & HealthCare
    The European Directorate for the Quality of Medicines & HealthCare is a Council of Europe body responsible for developing quality standards and guidance to ensure the safety and efficacy of medicines and improve healthcare across member states.
  • E. Management Board of the European Medicines Agency
    The Management Board of the European Medicines Agency is the governing body that oversees the agency’s strategy, budget, and overall operations in regulating medicines within the European Union.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c0085047dc8190af24e311edad3c07 completed March 22, 2026, 3:18 p.m.
NER Named-entity recognition batch_69c035f99b788190b5b06d83b9499bfa completed March 22, 2026, 6:33 p.m.
NED1 Entity disambiguation (via context triple) batch_69c0b11b48d88190ba6cd5ade2f47a89 completed March 23, 2026, 3:18 a.m.
Created at: March 22, 2026, 3:56 p.m.